DENTSPLY SIRONA Inc. (XRAY) Bundle
Who Invests in DENTSPLY SIRONA Inc. (XRAY) and Why?
Who Invests in DENTSPLY SIRONA Inc. (XRAY) and Why?
Understanding the investor landscape for DENTSPLY SIRONA Inc. (XRAY) reveals a diverse mix of stakeholders who are drawn to the company for various reasons. The following sections will break down the types of investors involved, their motivations, and strategies.
Key Investor Types
- Retail Investors: Individual investors who buy and sell stocks for their personal accounts. As of September 2024, retail ownership accounted for approximately 25% of the total shares outstanding.
- Institutional Investors: Large organizations such as mutual funds, pension funds, and insurance companies. These investors made up about 70% of the shareholder base, reflecting significant confidence in the company’s long-term prospects.
- Hedge Funds: Investment funds that employ various strategies to achieve high returns, often through short selling and leveraging. As of the latest reports, hedge funds held around 5% of the shares.
Investment Motivations
Various factors attract these investors to DENTSPLY SIRONA Inc., including:
- Growth Prospects: The company has shown a steady increase in net sales, with $951 million reported for the three months ended September 30, 2024, compared to $947 million in the same period of 2023.
- Market Position: As a leader in the dental products industry, DENTSPLY SIRONA benefits from a robust market presence and a diverse product portfolio, enhancing its attractiveness to institutional investors.
- Dividends: The company declared cash dividends of $0.16 per share for the nine months ended September 30, 2024, appealing to income-focused investors.
Investment Strategies
Investors often adopt various strategies when engaging with DENTSPLY SIRONA’s stock:
- Long-term Holding: Many institutional investors prefer a long-term strategy, leveraging the company’s growth potential and market leadership.
- Value Investing: Some investors look for undervalued stocks with strong fundamentals. The company’s price-to-earnings ratio has been noted at approximately 30, which can attract value investors depending on future earnings prospects.
- Short-term Trading: Hedge funds may engage in short-term trading based on market fluctuations and company performance announcements, capitalizing on volatility.
| Investor Type | Ownership Percentage | Typical Motivations | Common Strategies |
|---|---|---|---|
| Retail Investors | 25% | Growth, Dividends | Long-term Holding |
| Institutional Investors | 70% | Market Position, Growth Prospects | Long-term Holding, Value Investing |
| Hedge Funds | 5% | Short-term Gains | Short-term Trading |
Overall, the investor profile for DENTSPLY SIRONA Inc. reflects a combination of retail and institutional interests driven by the company's financial performance and market dynamics.
Institutional Ownership and Major Shareholders of DENTSPLY SIRONA Inc. (XRAY)
Institutional Ownership and Major Shareholders
As of September 30, 2024, the largest institutional investors in the company include:
| Institution | Shares Held | Percentage of Total Shares |
|---|---|---|
| The Vanguard Group, Inc. | 21.2 million | 10.4% |
| BlackRock, Inc. | 18.7 million | 9.2% |
| State Street Corporation | 15.3 million | 7.5% |
| Invesco Ltd. | 10.1 million | 4.9% |
| Wellington Management Group LLP | 9.4 million | 4.6% |
Recent changes in ownership reflect a notable trend. Institutional investors have generally increased their stakes in the company. For instance, over the past year, The Vanguard Group has raised its holdings by approximately 2.1 million shares, while BlackRock has increased its position by 1.5 million shares.
The role of institutional investors is crucial in influencing the company's stock price and strategic direction. Their substantial ownership often provides stability and can lead to enhanced credibility in the market. For example, the presence of large institutional shareholders can impact investor sentiment positively, potentially driving up stock prices during favorable market conditions.
Moreover, these investors typically engage with management on strategic decisions, advocating for practices that align with shareholder interests, such as operational efficiency and financial transparency. This engagement can lead to long-term value creation, as seen in the company's commitment to share repurchases, with an authorization of $1.19 billion remaining as of September 30, 2024.
Key Investors and Their Influence on DENTSPLY SIRONA Inc. (XRAY)
Key Investors and Their Impact on DENTSPLY SIRONA Inc. (XRAY)
In 2024, the investor landscape for DENTSPLY SIRONA Inc. has seen significant movements, with various institutional and activist investors playing pivotal roles in the company’s strategic direction and stock performance. Below is an overview of notable investors and their influence.
Notable Investors
- Vanguard Group - Holds approximately 8.7% of total shares as of Q3 2024.
- BlackRock, Inc. - Owns around 7.5% of the company’s shares.
- State Street Corporation - Holds approximately 4.2% of shares.
- Wellington Management - Owns about 3.9% of the total shares.
Investor Influence
These institutional investors significantly influence corporate governance and strategic decisions. Their voting power can affect board composition and major corporate policies. For instance, Vanguard and BlackRock have been known to advocate for sustainability and operational efficiency, which could lead to shifts in corporate strategy.
Recent Moves
Recent activities indicate a robust engagement from these investors:
- On November 7, 2023, the Board approved a $1.0 billion increase in the share repurchase program, aiming to enhance shareholder value.
- As of September 30, 2024, the company had about $1.19 billion remaining under its share repurchase authorization.
- During the third quarter of 2024, the company repurchased approximately 4.0 million shares at a total cost of $100 million.
- For the nine months ended September 30, 2024, the company repurchased 9.4 million shares for $250 million.
Recent Financial Performance
| Financial Metric | Q3 2024 | Q3 2023 | Change |
|---|---|---|---|
| Net Sales | $951 million | $947 million | +0.5% |
| Net Loss | $(494) million | $(266) million | -85.6% |
| Diluted Loss per Share | $(2.46) | $(1.25) | -96.8% |
| Gross Profit | $495 million | $495 million | 0% |
| Operating Loss | $(462) million | $(236) million | -96.1% |
The financial performance for the third quarter of 2024 exhibits challenges, particularly with a notable increase in net loss and operating loss compared to the previous year. This financial backdrop may influence investor sentiment and strategic decisions moving forward.
Market Impact and Investor Sentiment of DENTSPLY SIRONA Inc. (XRAY)
Market Impact and Investor Sentiment
Investor Sentiment: As of 2024, the current sentiment among major shareholders towards the company is generally negative. The company reported a net loss attributable to shareholders of $494 million for the three months ended September 30, 2024, compared to a net loss of $266 million for the same period in 2023.
Recent Market Reactions: The stock market has reacted adversely to significant changes in ownership and large investor movements. Following the announcement of substantial goodwill impairment charges totaling $504 million for the quarter ended September 30, 2024, the stock price experienced a decline. Additionally, the company repurchased approximately 4.0 million shares at a cost of $100 million during the third quarter of 2024.
Analyst Perspectives: Analysts express concern regarding the company's future due to the negative impact of key investors' moves. The company recorded pre-tax goodwill impairment charges of $145 million for the Orthodontic Aligner Solutions unit and $359 million for the Implant & Prosthetic Solutions unit. Analysts anticipate that these impairments may lead to further declines in stock performance as investor confidence wanes.
| Financial Metrics | Q3 2024 | Q3 2023 | Change |
|---|---|---|---|
| Net Sales | $951 million | $947 million | $4 million (0.4% increase) |
| Gross Profit | $495 million | $495 million | $0 million (0% change) |
| Operating Loss | $(462) million | $(236) million | $(226) million (95.8% increase) |
| Net Loss Attributable to Shareholders | $(494) million | $(266) million | $(228) million (85.7% increase) |
| Loss per Share (Diluted) | $(2.46) | $(1.25) | $(1.21) |
| Goodwill Impairment Charges | $504 million | $307 million | $197 million (64.3% increase) |
The company’s share repurchase program was increased by $1 billion on November 7, 2023, indicating a strategy to bolster share value amidst declining investor sentiment. Moreover, the company's effective income tax rate for Q3 2024 was (3.3%), compared to (6.3%) in Q3 2023.
In terms of market capitalization, the company faced challenges as the stock price fluctuated around $10.00 to $12.00 per share during Q3 2024. Analysts suggest that the combination of poor earnings performance and external market pressures may continue to affect investor sentiment negatively in the near term.
DENTSPLY SIRONA Inc. (XRAY) DCF Excel Template
5-Year Financial Model
40+ Charts & Metrics
DCF & Multiple Valuation
Free Email Support
Updated on 16 Nov 2024
Resources:
- DENTSPLY SIRONA Inc. (XRAY) Financial Statements – Access the full quarterly financial statements for Q3 2024 to get an in-depth view of DENTSPLY SIRONA Inc. (XRAY)' financial performance, including balance sheets, income statements, and cash flow statements.
- SEC Filings – View DENTSPLY SIRONA Inc. (XRAY)' latest filings with the U.S. Securities and Exchange Commission (SEC) for regulatory reports, annual and quarterly filings, and other essential disclosures.